+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nutra Pharma Corp (NPHC) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 36 Pages
  • December 2022
  • GlobalData
  • ID: 1322571
Nutra Pharma Corp (NPHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Nutra Pharma Corp (Nutra Pharma) acquires, licenses, and commercializes pharmaceutical products and technologies, ethical drugs for managing cancer and homeopathic drugs, neurological disorders, autoimmune and infectious diseases, including human Immunodeficiency virus (HIV), multiple sclerosis (MS), adrenomyeloneuropathy (AMN) and pain. It also markets over-the-counter (OTC) pain management products under the brands Nyloxin and Pet Pain-Away. The company's wholly owned subsidiaries include Designer Diagnostics, which markets and sells rapid diagnostics test kits for infectious diseases; and ReceptoPharm, which develops proprietary therapeutic protein products for the prevention and treatment of viral and neurological diseases. Nutra Pharma is headquartered in Coral Springs, Florida, the US.

Nutra Pharma Corp Key Recent Developments

  • Mar 23, 2022: Nutra Pharma announces first manufacturing agreement
  • Mar 17, 2022: Nutra pharma expands manufacturing capabilities
  • Jul 26, 2021: Nutra Pharma provides business and compliance updates

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Nutra Pharma Corp - Key Facts
  • Nutra Pharma Corp - Key Employees
  • Nutra Pharma Corp - Key Employee Biographies
  • Nutra Pharma Corp - Major Products and Services
  • Nutra Pharma Corp - History
  • Nutra Pharma Corp - Company Statement
  • Nutra Pharma Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Nutra Pharma Corp - Business Description
  • R&D Overview
  • Nutra Pharma Corp - Corporate Strategy
  • Nutra Pharma Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Nutra Pharma Corp - Strengths
  • Nutra Pharma Corp - Weaknesses
  • Nutra Pharma Corp - Opportunities
  • Nutra Pharma Corp - Threats
  • Nutra Pharma Corp - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Recent Developments
  • Mar 23, 2022: Nutra Pharma announces first manufacturing agreement
  • Mar 17, 2022: Nutra pharma expands manufacturing capabilities
  • Jul 26, 2021: Nutra Pharma provides business and compliance updates
Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Nutra Pharma Corp, Key Facts
  • Nutra Pharma Corp, Key Employees
  • Nutra Pharma Corp, Key Employee Biographies
  • Nutra Pharma Corp, Major Products and Services
  • Nutra Pharma Corp, History
  • Nutra Pharma Corp, Subsidiaries
  • Nutra Pharma Corp, Key Competitors
  • Nutra Pharma Corp, Annual Ratios
  • Nutra Pharma Corp, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Nutra Pharma Corp, Performance Chart (2017 - 2021)
  • Nutra Pharma Corp, Ratio Charts

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Amgen Inc
  • Regeneron Pharmaceuticals Inc
  • Novartis AG
  • Genzyme Corp
  • Bayer AG